Circadian variation of urinary microalbumin excretion and ambulatory blood pressure in patients with essential hypertension

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 2101-2108

  Hishiki, Satoshi ^b   Tochikubo, Osamu ^a   Miyajima, Eiji ^b   Ishii, Masao ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE

Author keywords

Circadian variation; Essential hypertension; Microalbuminuria

Indexed keywords

ALBUMIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; HORMONE;

ACCELERATION; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; AMBULATORY MONITORING; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; STRESS;

EID: 0032435966     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00036     Document Type: Conference Paper

References (36)

1. Kannal WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984; 108:1347-1352.
2. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984; 310:356-360.
3. Deckert T, Koford-Enevoldsen A, Norgaard K, Borch-Johnson K, Feldt-Rassmudsen B, Jensen T. Microalbuminuria: implications for micro and macrovascular disease. Diabetes Care 1992;15:1181-1191.
4. Parving HH, Jensen H, Mogensen CE, Ervin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; 15:1190-1192.
5. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61:94-97.
6. Gerber LM, Shmukler C, Alderman MH. Differences in urinary albumin excretion rate between normotensive and hypertensive, white and non-white subjects. Arch Intern Med 1992; 152:373-377.
7. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988; 2:530-533.
8. Cersola G, Cottons S, D'Ignoto G, Grasso L, Mangano MT, Carapelle E, et al. Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989; 7:(suppl 6):S332-S333.
9. Pedersen EB, Mogensen CE. Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. Scand J Clin Lab Invest 1976; 36:231-237.
10. Opsal JA, Abraham PA, Halstensen CE, Keane WF. Correlation of office and ambulatory blood pressure measurements with urinary albumin and N-acetyl-D-glucosaminidase excretions in essential hypertension. Am J Hypertens 1988; 1(suppl 1):117s-120s.
11. Hoeghholm A, Bang LE, Kristensen KJ, Nielsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 994; 24:101-105.
12. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Pall L, et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989; 2:259-261.
13. Redon J, Liao Y, Lozano JV. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994; 12:947-953.
14. Mogensen CE, Vittinghus E. Urinary albumin excretion during exercise in juvenile diabetes. A provocation test for early abnormalities. Scand J Clin Lab Invest 1975; 35:295-300.
15. Viberti GC, Jarrett RJ, McCortney M, Keen H. Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia 1978; 14:293-300.
16. 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment. Scad J Clin Lab Invest 1981; 41:493-498.
17. West JNW, Gosling P, Dimmit SB, Littler WA: Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci 1991; 81:373-377.
18. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multimedical recorder. J Hypertens 1996; 27:1318-1324.
19. Jungmann E, Felber S, Graeber S, Hillman U, Haak T, Palitzsch K-D, et al. Human atrial natriureric peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy? Clin Invest 1993; 71:604-609.
20. Zietse R, Derkx FH, Weimer W, Schalekamp MA. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J. Am. Soc. Nephrol 1995; 5:2057-2066.
21. American National Standard. Electronic or Automated Sphygmomanometers. Arlington, Va: Association for the Advancement of Medical Instrumentation; 1993:1-39.
22. O'Brien E, Petrie J, Littler WA, De Swiet M, Padfield PL, O'Malley K, et al. The British Hypertension Society protocol for the evaluation of automated and semiautomated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1991; 5:77-82.
23. Tochikubo O, Shigemasa T, Miyajima E, Ishii M, Nagashima T, Ishizuka S. The development of a new portable multi-biomedical recorder and its accuracy of blood pressure measurement. Ther Res 1996; 17:1966-1972.
24. Mogensen CE. Microalbuminuria as a predictor of clinical nephropathy. Kidney Int 1987; 31:673-689.
25. De Leeuw P, Birkenhager WH. The renal circulation in essential hypertension. J Hypertens 1983; 1:321-333.
26. Ljungman S, Aurell M, Hartford M, Wirkstrand J, Wilhelmsen L, Berglund G. Blood pressure and renal function. Acta Med Scand 1980; 208:17-25.
27. Cristensen CK, Krusell LR, Mogensen CE. Increased blood pressure in diabetes: essential hypertension or diabetic nephropathy? Scand J Clin Lab Invest 1987; 47:363-370.
28. Mauer SM, Steffes MW, Brown DM. The kidney in diabetes. Am J Med 1981; 70:603.
29. Poortmans JR. Exercise and renal function. Exerc Sport Sci Rev 1977; 5:255-294.
30. Mogensen CE, Osterby R, Gundersen HJG. Early functional and morphologic vascular renal consequences of the diabetic state. Diabetologia 1979; 17:71.
31. Zander E, Schulz B, Heinke P, Grimmberger E, Zander G, Gottschling HD. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care 1989; 12:259-264.
32. Molgaard J, Christensen PD, Sorensen KE, Christensen CK, Mogensen CE. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992; 41:812-817.
33. Kohno M, Yasunari K, Matsuura T, Murakawa K, Takeda T. Circulating atrial natriuretic polypeptide in essential hypertension. Am Heart J 1987; 113:1160-1163.
34. Kangawa K, Matsuo H. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Commun 1984; 118:131-139.
35. Ishihara T, Aisaka K, Hattori K, Hamasaki S, Morita M, Noguchi T, et al. Vasodilatory and diuretic action of α-human natriuretic polypeptide (α-hANP). Life Sci 1985; 36:1205-1211.
36. Ishii M, Hirata Y, Sugimoto T, Matsuoka H, Kimura K, Ishimitu T, et al. Effect of α-human atrial natriuretic peptide on proteinuria in patients with primary glomerular diseases. Clin Sci 1989; 77: 643-650.